Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 284,803 | 752,243 | 791,861 | 823,984 | 848,537 |
| Marketable Securities | 328,359 | N/A | N/A | N/A | N/A |
| Receivables | 2,435 | 4,563 | 4,004 | 4,619 | 12,090 |
| TOTAL | $628,298 | $768,546 | $804,743 | $840,660 | $874,713 |
| Non-Current Assets | |||||
| PPE Net | 2,121 | 2,095 | 2,271 | 2,216 | 2,072 |
| Investments And Advances | 118,225 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6,347 | 7,232 | 7,760 | 7,445 | 7,927 |
| TOTAL | $126,693 | $9,327 | $10,031 | $9,661 | $9,999 |
| Total Assets | $754,991 | $777,873 | $814,774 | $850,321 | $884,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,662 | 9,603 | 10,921 | 10,603 | 5,145 |
| Accrued Expenses | 19,727 | 11,379 | 13,806 | 14,052 | 17,157 |
| TOTAL | $42,000 | $93,831 | $125,395 | $174,253 | $304,124 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,775 | 67,485 | 86,925 | 128,705 | 281,052 |
| Other Non-Current Liabilities | 49,659 | 49,843 | 52,078 | 49,690 | 27,768 |
| TOTAL | $49,659 | $49,843 | $52,078 | $49,690 | $27,768 |
| Total Liabilities | $91,659 | $143,674 | $177,473 | $223,943 | $331,892 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,720 | 35,575 | 35,575 | 35,541 | 35,515 |
| Common Shares | 36 | 36 | 36 | 36 | 35 |
| Retained earnings | 237,275 | 216,822 | 215,831 | 210,205 | 140,623 |
| Other shareholders' equity | -9,644 | -12,125 | -2,309 | -1,568 | -1,018 |
| TOTAL | $663,332 | $634,199 | $637,301 | $626,378 | $552,820 |
| Total Liabilities And Equity | $754,991 | $777,873 | $814,774 | $850,321 | $884,712 |